Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Systematic Literature Review of the Economic Burden and Cost of Illness in Patients with Myelofibrosis

Derek Tang, PhD BSPharm, Ankush Taneja, Preety Rajora, Renu Patel

Blood (2019) 134 (Supplement_1): 2184.

https://doi.org/10.1182/blood-2019-122919

Published: 2019

Journal Articles

An Educational Study Promoting the Delivery of TCD Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective

Baba PD Inusa, MD, Corrina Macmahon, MD, Laura Sainati, MD, Raffaella Colombatti, MD PhD, Maddalena Casale, MD PhD, Patrizia Rampazzo, MD, Silverio Perrotta, Soundrie Padayachee

Blood (2019) 134 (Supplement_1): 2172.

https://doi.org/10.1182/blood-2019-130390

Published: 2019

Journal Articles

Interim Analysis of a Prospective Multicentre Study Using Next Generation Sequencing for Kinase Domain Mutational Analysis in CML Patients on First or Subsequent TKI Therapy

Blood (2019) 134 (Supplement_1): 2935.

https://doi.org/10.1182/blood-2019-129825

Published: 2019

Journal Articles

Targeting CD38 high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Emma Nolan, BSc, Arwen Stikvoort, PhD, Mark Gurney, MD, Nutsa Burduli, BSc, Lucy Kirkham-McCarthy, MSc, John Daly, MSc, Niels W. C. J. Van De Donk, Tuna Mutis, MD PhD, Subhashis Sarkar, PhD, Michael E O'Dwyer, MD

Blood (2019) 134 (Supplement_1): 5536.

https://doi.org/10.1182/blood-2019-128605

Published: 2019

Journal Articles

Procarbazine-Free Escalated Beacopdac in Frontline Therapy of Advanced Hodgkin Lymphoma Reduces Red Cell Transfusion Requirements and May Shorten Time to Menstrual Period Recovery Compared to Escalated Beacopp and Appears to be As Efficacious

Blood (2019) 134 (Supplement_1): 1564.

https://doi.org/10.1182/blood-2019-125256

Published: 2019

Journal Articles

UK CLL Forum 5 Year Update on 315 Relapsed Refractory CLL Patients Treated with Ibrutinib in 66 UK and Ireland Centres

UK CLL Forum, George A Follows, MD PhD

Blood (2019) 134 (Supplement_1): 1768.

https://doi.org/10.1182/blood-2019-123199

Published: 2019

Journal Articles

Socially Excluded Persons in Ireland Have an Increased Annual Risk of Hospitalisation Due to Venous Thromboembolic Disease

Karl Ewins, Fionnuala Ni Ainle, PhD, Eoghan Dunlea, MB BCh MRCPI, Sarah Kelliher, MBBS, Vicky Sandys, MB BCh MRCPI, Hannorah Rooney, BM BCh MRCPI, Lily Macken, MB BCh MRCPI, Ni Cheallaigh Cliona, MB BCH MRCPI PhD

Blood (2019) 134 (Supplement_1): 4702.

https://doi.org/10.1182/blood-2019-130371

Published: 2019

Journal Articles

Higher Rates of Death and Major Bleeding Highlight the Inequities That Exist in the Care of People with Venous Thromboembolism Who Experience Social Exclusion: Findings from a Prospective Registry of 79735 Patients (RIETE)

Karl Ewins, Fionnuala Ni Ainle, PhD, Cliona Ni Cheallaigh, MB BCH MRCPI PhD, Eoghan Dunlea, MB BCh MRCPI, Sarah Kelliher, MBBS, Egidio Imbalzano, MD, Cristiano Bortoluzzi, MD, Inés Jou, MD, Joaquín Alfonso-Megido, María del Carmen Díaz-Pedroche, Manuel Monreal, MD PhD

Blood (2019) 134 (Supplement_1): 4677.

https://doi.org/10.1182/blood-2019-130745

Published: 2019

Journal Articles

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Michael Ellison, PhD, Natalie Briones, MS, Angelina Baroffio, John Murphy, Katherine Gowan, Bridget Sanford, Kenneth L. Jones, PhD, Daniel R. Ambruso, MD

Blood (2018) 132 (Supplement 1): 2398.

https://doi.org/10.1182/blood-2018-99-115314

Published: 2018

Journal Articles

Effects of Interferon-Gamma 1-b (IFN-Î³) on Neutrophil Function and Biochemistry in Patients with Chronic Granulomatous Disease

Daniel R. Ambruso, MD, Michael Ellison, PhD, Natalie Briones, MS, Alexander Tran, MS

Blood (2018) 132 (Supplement 1): 2400.

https://doi.org/10.1182/blood-2018-99-115683

Published: 2018

Journal Articles

Estimating the Burden of Hospital-Acquired Venous Thromboembolism: The Argument for Implementation of Mandatory Risk Reduction Strategies

Barry Kevane, MB, PhD, Mary Day, PhD, Noirin Bannon, Leo Lawler, MB, Tomas Breslin, MB, Claire Andrews, MB, Howard Johnson, PhD, Michael Fitzpatrick, Karen Murphy, MD, Olivia Mason, MSc, Sarah Kelliher, MB, Annemarie O'Neill, Fionnuala Donohue, Fionnuala Ni Ainle, MD PhD

Blood (2018) 132 (Supplement 1): 3515.

https://doi.org/10.1182/blood-2018-99-112143

Published: 2018

Journal Articles

Preliminary Outcomes of Children and Young Adults with Acute Lymphoblastic Leukaemia and Down Syndrome (DS-ALL) on UKALL 2011. Reduction in Treatment-Related Mortality with De-Escalated Therapy

Sara Ghorashian, FRCPath, PhD, Sujith Samarasinghe, Amy A Kirkwood, MSc, Rachael Hough, MD BMBS, FRCP, FRCPath, Clare Rowntree, MD, Sarah Lawson, MD, Nicholas John Goulden, MD PhD MRCPath, Emma Pond, PhD, Pamela R. Kearns, PhDFRCPC, Anthony V. Moorman, PhD, John Moppett, Ajay Vora, MD

Blood (2018) 132 (Supplement 1): 656.

https://doi.org/10.1182/blood-2018-99-118426

Published: 2018

Journal Articles

Ex Vivo Co-Culture of AML Blasts and Bone Marrow Mesenchymal Stromal Cells to Accurately Predict the Clinical Efficacy of Cytarabine-Daunorubicin Treatment

Sukhraj Pal Singh Dhami, MSc, BSc, Andrea Tirincsi, MSc, BSc, Denis V Baev, PhD, Janusz Krawczyk, MD, John Quinn, MD PhD, Eva Szegezdi, PhD

Blood (2018) 132 (Supplement 1): 2636.

https://doi.org/10.1182/blood-2018-99-118619

Published: 2018

Journal Articles

The Population of Circulating Extracellular Vesicles Dramatically Alters after Very Premature Delivery- a Previously Unrecognised Postnatal Adaptation Process?

Daniel O'Reilly, MBBS, BSc, Karl Egan, PhD, Oscar Burke, BSc, Angharad Griffiths, Elaine Neary, MD, Alfonso Blanco, PhD, Paulina Szklanna, PhD, Patricia Maguire, PhD, Naomi McCallion, Fionnuala Ni Ainle, MD PhD

Blood (2018) 132 (Supplement 1): 1129.

https://doi.org/10.1182/blood-2018-99-113180

Published: 2018

Journal Articles

The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

Dearbhla Doherty, MB, MRCPI, Anjali Patel, Margaret Nolan, Mary Byrne, Sonia Aguila, PhD, Jamie M O'Sullivan, Kevin Ryan, MB, FRCPath, Niamh M O'Connell, MB, PhD FRCPath, Michelle Lavin, MB, PhD FRCPath, James S O'Donnell, MD PhD

Blood (2018) 132 (Supplement 1): 1178.

https://doi.org/10.1182/blood-2018-99-115946

Published: 2018

Journal Articles

Should Myelodysplastic Syndromes in Very Old Patients be More Actively Managed? Clinical Characteristics, Management and Outcomes for Patients 85 Years and Older

Laura McDonald, MB MRCPI, Peter McCarthy, MB BCh BAO, Mohammad Khan, MD, Patrick Hogan, MB BCh BAO, Eileen C. Kelleher, MD, Philip Murphy, MD, John Quinn, MD PhD, Ronan Desmond, MD, Johnny McHugh, MB, FRPATH, Melanie Strickland, BNS, Mary Cahill, MD, Su Wai Maung, MRCP, MBBS, Clodagh Keohane, MD, Desmond O'Neill, MD, Daniel Ryan, MD, Vitaliy Mykytiv, MD, Helen Enright, MD

Blood (2018) 132 (Supplement 1): 5515.

https://doi.org/10.1182/blood-2018-99-113290

Published: 2018

Journal Articles

Weekly CyborD-DARA Is a Safe and Effective Upfront Treatment for Newly Diagnosed Multiple Myeloma. Preliminary Results of the Early Phase 16-Bcni-001/Ctrial-IE (ICORG) 16-02 Study

Cian McEllistrim, MD, Mary R Cahill, MD, Philip Murphy, PhD BPharm, Vitaliy Mykytiv, MD, John Quinn, Amanda Bray, Jessica Walsh, Elizabeth Lenihan, Tara Kenny, Grace Hirakata, Imelda Parker, Andres Hernando, Michael O'Dwyer, MD

Blood (2017) 130 (Supplement 1): 3163.

https://doi.org/10.1182/blood.V130.Suppl_1.3163.3163

Published: 2017

Journal Articles

Multicentre Retrospective Analysis of Chronic Lymphocytic Leukaemia Patients Treated with Idelalisib, "Real World" Data from the UK and Republic of Ireland - a Cohort of 68 Patients

Blood (2017) 130 (Supplement 1): 1733.

https://doi.org/10.1182/blood.V130.Suppl_1.1733.1733

Published: 2017

Journal Articles

UKALL 2011: Randomised Trial Investigating a Short Induction Dexamethasone Schedule for Children and Young Adults with Acute Lymphoblastic Leukaemia

Nicholas John Goulden, MD PhD MRCPath, Amy A Kirkwood, John Moppett, MD, Sujith Samarasinghe, Sarah Lawson, MD, Clare Rowntree, MD, Rachael Hough, MD BMBS, FRCP, FRCPath, Rajbir Athwal, Pamela R. Kearns, PhDFRCPC, Ajay Vora, MD

Blood (2017) 130 (Supplement 1): 141.

https://doi.org/10.1182/blood.V130.Suppl_1.141.141

Published: 2017

Journal Articles

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

Michelle Lavin, Sonia Aguila, Sonja Schneppenheim, Niall Dalton, Kenneth L. Jones, Jamie M. O’Sullivan, Niamh M. O’Connell, Kevin Ryan, Barry White, Mary Byrne, Marie Rafferty, Mairead M. Doyle, Margaret Nolan, Roger J. S. Preston, Ulrich Budde, Paula James, Jorge Di Paola, James S. O’Donnell

Blood (2017) 130 (21): 2344–2353.

https://doi.org/10.1182/blood-2017-05-786699

Published: 2017

Includes: Supplemental data

NARROW

Systematic Literature Review of the Economic Burden and Cost of Illness in Patients with Myelofibrosis

An Educational Study Promoting the Delivery of TCD Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective

Interim Analysis of a Prospective Multicentre Study Using Next Generation Sequencing for Kinase Domain Mutational Analysis in CML Patients on First or Subsequent TKI Therapy

Targeting CD38 high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Procarbazine-Free Escalated Beacopdac in Frontline Therapy of Advanced Hodgkin Lymphoma Reduces Red Cell Transfusion Requirements and May Shorten Time to Menstrual Period Recovery Compared to Escalated Beacopp and Appears to be As Efficacious

UK CLL Forum 5 Year Update on 315 Relapsed Refractory CLL Patients Treated with Ibrutinib in 66 UK and Ireland Centres

Socially Excluded Persons in Ireland Have an Increased Annual Risk of Hospitalisation Due to Venous Thromboembolic Disease

Higher Rates of Death and Major Bleeding Highlight the Inequities That Exist in the Care of People with Venous Thromboembolism Who Experience Social Exclusion: Findings from a Prospective Registry of 79735 Patients (RIETE)

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Effects of Interferon-Gamma 1-b (IFN-Î³) on Neutrophil Function and Biochemistry in Patients with Chronic Granulomatous Disease

Estimating the Burden of Hospital-Acquired Venous Thromboembolism: The Argument for Implementation of Mandatory Risk Reduction Strategies

Preliminary Outcomes of Children and Young Adults with Acute Lymphoblastic Leukaemia and Down Syndrome (DS-ALL) on UKALL 2011. Reduction in Treatment-Related Mortality with De-Escalated Therapy

Ex Vivo Co-Culture of AML Blasts and Bone Marrow Mesenchymal Stromal Cells to Accurately Predict the Clinical Efficacy of Cytarabine-Daunorubicin Treatment

The Population of Circulating Extracellular Vesicles Dramatically Alters after Very Premature Delivery- a Previously Unrecognised Postnatal Adaptation Process?

The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

Should Myelodysplastic Syndromes in Very Old Patients be More Actively Managed? Clinical Characteristics, Management and Outcomes for Patients 85 Years and Older

Weekly CyborD-DARA Is a Safe and Effective Upfront Treatment for Newly Diagnosed Multiple Myeloma. Preliminary Results of the Early Phase 16-Bcni-001/Ctrial-IE (ICORG) 16-02 Study

Multicentre Retrospective Analysis of Chronic Lymphocytic Leukaemia Patients Treated with Idelalisib, "Real World" Data from the UK and Republic of Ireland - a Cohort of 68 Patients

UKALL 2011: Randomised Trial Investigating a Short Induction Dexamethasone Schedule for Children and Young Adults with Acute Lymphoblastic Leukaemia

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only